346 related articles for article (PubMed ID: 9815868)
1. Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium.
Hasenfuss G; Pieske B; Castell M; Kretschmann B; Maier LS; Just H
Circulation; 1998 Nov; 98(20):2141-7. PubMed ID: 9815868
[TBL] [Abstract][Full Text] [Related]
2. The role of cAMP- and cGMP-dependent protein kinases in the cardiac actions of the new calcium sensitizer, levosimendan.
Haikala H; Kaheinen P; Levijoki J; Lindén IB
Cardiovasc Res; 1997 Jun; 34(3):536-46. PubMed ID: 9231037
[TBL] [Abstract][Full Text] [Related]
3. Calcium sensitization as new principle of inotropic therapy in end-stage heart failure?
Zimmermann N; Boknik P; Gams E; Herzig JW; Neumann J; Scholz H
Eur J Cardiothorac Surg; 1998 Jul; 14(1):70-5. PubMed ID: 9726618
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of phosphodiesterase-3 by levosimendan is sufficient to account for its inotropic effect in failing human heart.
Orstavik O; Ata SH; Riise J; Dahl CP; Andersen GØ; Levy FO; Skomedal T; Osnes JB; Qvigstad E
Br J Pharmacol; 2014 Dec; 171(23):5169-81. PubMed ID: 24547784
[TBL] [Abstract][Full Text] [Related]
5. Effects of calcium sensitizers on intracellular calcium handling and myocardial energetics.
Hasenfuss G; Pieske B; Kretschmann B; Holubarsch C; Alpert NR; Just H
J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S45-51. PubMed ID: 8907130
[TBL] [Abstract][Full Text] [Related]
6. A quantitative comparison of functional and anti-ischaemic effects of the phosphodiesterase-inhibitors, amrinone, milrinone and levosimendan in rabbit isolated hearts.
Rump AF; Acar D; Klaus W
Br J Pharmacol; 1994 Jul; 112(3):757-62. PubMed ID: 7921599
[TBL] [Abstract][Full Text] [Related]
7. Effects of levosimendan on myocardial contractility and Ca2+ transients in aequorin-loaded right-ventricular papillary muscles and indo-1-loaded single ventricular cardiomyocytes of the rabbit.
Sato S; Talukder MA; Sugawara H; Sawada H; Endoh M
J Mol Cell Cardiol; 1998 Jun; 30(6):1115-28. PubMed ID: 9689586
[TBL] [Abstract][Full Text] [Related]
8. Troponin C-mediated calcium sensitization by levosimendan accelerates the proportional development of isometric tension.
Haikala H; Levijoki J; Lindén IB
J Mol Cell Cardiol; 1995 Oct; 27(10):2155-65. PubMed ID: 8576932
[TBL] [Abstract][Full Text] [Related]
9. Dual regulation of myofilament Ca2+ sensitivity by levosimendan in normal and acidotic conditions in aequorin-loaded canine ventricular myocardium.
Takahashi R; Endoh M
Br J Pharmacol; 2005 Aug; 145(8):1143-52. PubMed ID: 15951828
[TBL] [Abstract][Full Text] [Related]
10. Positive inotropic effect of levosimendan is correlated to its stereoselective Ca2+-sensitizing effect but not to stereoselective phosphodiesterase inhibition.
Kaheinen P; Pollesello P; Hertelendi Z; Borbély A; Szilágyi S; Nissinen E; Haikala H; Papp Z
Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):74-8. PubMed ID: 16433895
[TBL] [Abstract][Full Text] [Related]
11. Influence of temperature on the positive inotropic effect of levosimendan, dobutamine and milrinone.
Rieg AD; Schroth SC; Grottke O; Hein M; Ackermann D; Rossaint R; Schälte G
Eur J Anaesthesiol; 2009 Nov; 26(11):946-53. PubMed ID: 19687740
[TBL] [Abstract][Full Text] [Related]
12. Effects of levosimendan and milrinone on oxygen consumption in isolated guinea-pig heart.
Kaheinen P; Pollesello P; Levijoki J; Haikala H
J Cardiovasc Pharmacol; 2004 Apr; 43(4):555-61. PubMed ID: 15085067
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of the Ca(2+) sensitizer levosimendan in human myocardium.
Brixius K; Reicke S; Schwinger RH
Am J Physiol Heart Circ Physiol; 2002 Jan; 282(1):H131-7. PubMed ID: 11748056
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2 consumption in dogs.
Banfor PN; Preusser LC; Campbell TJ; Marsh KC; Polakowski JS; Reinhart GA; Cox BF; Fryer RM
Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H238-48. PubMed ID: 17982006
[TBL] [Abstract][Full Text] [Related]
15. Troponin C-mediated calcium sensitization induced by levosimendan does not impair relaxation.
Haikala H; Nissinen E; Etemadzadeh E; Levijoki J; Lindén IB
J Cardiovasc Pharmacol; 1995 May; 25(5):794-801. PubMed ID: 7630157
[TBL] [Abstract][Full Text] [Related]
16. Effects of Levosimendan, a cardiotonic agent targeted to troponin C, on cardiac function and on phosphorylation and Ca2+ sensitivity of cardiac myofibrils and sarcoplasmic reticulum in guinea pig heart.
Edes I; Kiss E; Kitada Y; Powers FM; Papp JG; Kranias EG; Solaro RJ
Circ Res; 1995 Jul; 77(1):107-13. PubMed ID: 7788868
[TBL] [Abstract][Full Text] [Related]
17. The effects of milrinone and piroximone on intracellular calcium handling in working myocardium from the ferret.
Gwathmey JK; Morgan JP
Br J Pharmacol; 1985 May; 85(1):97-108. PubMed ID: 2992656
[TBL] [Abstract][Full Text] [Related]
18. Effects of levosimendan on myocardial contractility and oxygen consumption.
Todaka K; Wang J; Yi GH; Stennett R; Knecht M; Packer M; Burkhoff D
J Pharmacol Exp Ther; 1996 Oct; 279(1):120-7. PubMed ID: 8858984
[TBL] [Abstract][Full Text] [Related]
19. Systemic and coronary hemodynamic actions and left ventricular functional effects of levosimendan in conscious dogs.
Harkin CP; Pagel PS; Tessmer JP; Warltier DC
J Cardiovasc Pharmacol; 1995 Aug; 26(2):179-88. PubMed ID: 7475041
[TBL] [Abstract][Full Text] [Related]
20. Levosimendan, a new inotropic and vasodilator agent.
Toller WG; Stranz C
Anesthesiology; 2006 Mar; 104(3):556-69. PubMed ID: 16508404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]